相关实验视频

Updated: Jun 17, 2026

Determination of Chemical Inhibitor Efficiency against Intracellular Toxoplasma Gondii Growth Using a Luciferase-Based Growth Assay

Determination of Chemical Inhibitor Efficiency against Intracellular Toxoplasma Gondii Growth Using a Luciferase-Based Growth Assay

Published on: April 29, 2020

酸--合氧化:分子对接,合成,表征和对Trypanosoma evansi的Trypanocidal活动

Anju Manuja¹, Ruma Rani¹, Nisha Devi¹

¹ICAR-National Research Centre on Equines, Hisar 125001, India.

|October 16, 2024

概括

新型酸盐-氧化物纳米颗粒与氧化结合,对Trypanosoma evansi.表现出强烈的活性. 这种新配方有效地抑制了关键的寄生虫蛋白质,并为治疗松症提供了一个有前途的替代方案.

科学领域:

药用化学医学化学
纳米技术纳米技术
寄生虫学的寄生虫学

背景情况:

现有的Trypanosoma evansi感染治疗方法受到药物耐药性,毒性和复发率的限制.
对于具有更好的疗效和安全性概况的新型抗寄生虫药物有着至关重要的需求.

研究的目的:

为了合成和描述新的基于金属的抗寄生虫化合物,使用奇托,氧化 (HC) 和氧化纳米颗粒 (ZnO NPs).
评估这些新型化合物对Trypanosoma evansi的in silico和in vitro疗效.

主要方法:

酸-结合化 (CsHCZnONPs) 的合成和表征,包括大小,形态和化学相互作用.
在基分子对接和蛋白质相互作用研究中,针对Hsp90和松减少酶.
在体外试验中测试类的活性,并评估T. evansi. 对离子吸收的评估.

主要成果:

CsHCZnONPs成功合成和表征,证明了稳定性和所需的物理化学性质.
在 silico 研究中,CsHCZnONPs 强烈抑制了 Hsp90 和三甲基减少酶,与HC和HCZnONPs相比,其活性更强.
实验室试验证实了CsHCZnONPs对T. evansi的显著的tripanocidal活性,导致72小时后在测试度下完全抑制生长. 寄生虫吸收的情况也得到证实.

结论:

素氧化物纳米颗粒与氧化代表了针对Trypanosoma evansi.的新且有效的治疗策略.
CsHCZnONPs的增强疗效归因于奇托,氧化和氧化纳米颗粒的协同作用.
这种创新的配方具有显著的潜力,可以开发出更安全,更有效的松症治疗方法.

关键词:

基多酸盐的使用方法氧化chloroquine 的使用情况分子对接的分子对接.这种药物具有特里帕诺西德活性.,和的使用情况.

更多相关视频

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

相关概念视频

Leishmaniasis

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...

American Trypanosomiasis

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...

Antiprotozoal Agents

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...